Pump therapies
Continuous intestinal levodopa-carbidopa gel (LCIG / Duopa), foslevodopa subcutaneous infusion (Vyalev / Produodopa) and apomorphine pumps for advanced fluctuations.
State of the art
No update yet for Pump therapies. An update is a standalone state-of-the-art for the topic — what someone with Parkinson's needs to know about where this approach stands today.
-
Vyalev eases motor, nonmotor symptoms in advanced Parkinson’s
Six-month real-world data from the ROSSINI observational study (n=105 newly treated patients) show Vyalev (foslevodopa/foscarbidopa subcutaneous infusion) cut daily off time by ~53% and dyskinesia time by ~53% in advanced Parkinson's — the first prospective real-world evidence for this pump therapy since its recent approval.